Hyperpolarized [1-13C]dehydroascorbate MR spectroscopy in a murine model of prostate cancer: Comparison with 18F-FDG PET

Journal of Nuclear Medicine

Volumn 54, Issue 6, 2013, Pages 922-928

  Keshari, Kayvan R ^a   Sai, Victor ^a   Wang, Zhen J ^a   VanBrocklin, Henry F ^a   Kurhanewicz, John ^a   Wilson, David M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ascorbate; FDG; Hyperpolarized; Positron emission tomography; Redox

Indexed keywords

1 DEHYDROASCORBATE C 13; CARRIER PROTEIN; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; GLUTATHIONE; PROTEIN SVCT1; PROTEIN SVCT2; RADIOPHARMACEUTICAL AGENT; THIOL; UNCLASSIFIED DRUG; ASCORBIC ACID; DEHYDROASCORBIC ACID; DIAGNOSTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPERPOLARIZATION; IMMUNOHISTOCHEMISTRY; MALE; METABOLITE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION REDUCTION STATE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; RADIOACTIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DISEASE MODEL; FDG; HYPERPOLARIZED; METABOLISM; PROSTATE TUMOR; REDOX; SCINTISCANNING; TRANSPORT AT THE CELLULAR LEVEL;

ASCORBATE; FDG; HYPERPOLARIZED; POSITRON EMISSION TOMOGRAPHY; REDOX;

ANIMALS; BIOLOGICAL TRANSPORT; DEHYDROASCORBIC ACID; DISEASE MODELS, ANIMAL; FLUORODEOXYGLUCOSE F18; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS;

MLCS; MLOWN;

EID: 84878628401     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.115402     Document Type: Article

References (37)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.
2. Al-Mamgani A, Lebesque JV, Heemsbergen WD, et al. Controversies in the treatment of high-risk prostate cancer: what is the optimal combination of hormonal therapy and radiotherapy: a review of literature. Prostate. 2010;70:701-709.
3. Nichol A, Chung P, Lockwood G, et al. A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapy. Radiother Oncol. 2005;76:11-17. (Pubitemid 41096509)
4. Mahdy AE, Cheng JC, Li J, et al. Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer. Mol Ther. 2009;17:430-438.
5. Kong Z, Xie D, Boike T, et al. Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation. Cancer Res. 2010;70:2829-2839.
6. Lu JP, Monardo L, Bryskin I, et al. Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidase. Prostate Cancer Prostatic Dis. 2010;13:39-46.
7. Sun Y, St Clair DK, Xu Y, Crooks PA, St Clair WH. A NADPH oxidase-dependent redox signaling pathway mediates the selective radiosensitization effect of parthenolide in prostate cancer cells. Cancer Res. 2010;70:2880-2890.
8. Husbeck B, Peehl DM, Knox SJ. Redox modulation of human prostate carcinoma cells by selenite increases radiation-induced cell killing. Free Radic Biol Med. 2005;38:50-57. (Pubitemid 39626908)
9. Sainz RM, Reiter RJ, Tan DX, et al. Critical role of glutathione in melatonin enhancement of tumor necrosis factor and ionizing radiation-induced apoptosis in prostate cancer cells in vitro. J Pineal Res. 2008;45:258-270.
10. Husbeck B, Nonn L, Peehl DM, Knox SJ. Tumor-selective killing by selenite in patient-matched pairs of normal and malignant prostate cells. Prostate. 2006;66:218-225. (Pubitemid 43191243)
11. Guzman ML, Li X, Corbett CA, et al. Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8). Blood. 2007;110:4436-4444. (Pubitemid 351377810)
12. Borghini M. Spin-temperature model of nuclear dynamic polarization using free radicals. Phys Rev Lett. 1968;20:419.
13. Deboer W, Borghini M, Morimoto K. Niinikos TO, Udo F. Sizeable pure tensor polarization of deuterons in a solid. Phys Lett A. 1973;A-46:143-144.
14. Abragam A, Goldman M. Principles of dynamic nuclear-polarization. Rep Prog Phys. 1978;41:395-467.
15. Ardenkjaer-Larsen JH, Fridlund B, Gram A, et al. Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR. Proc Natl Acad Sci USA. 2003;100:10158-10163. (Pubitemid 37071849)
16. Golman K, Ardenkjaer-Larsen JH, Petersson JS, Mansson S, Leunbach I. Molecular imaging with endogenous substances. Proc Natl Acad Sci USA. 2003;100:10435-10439. (Pubitemid 37071896)
17. 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Res. 2008;68:8607-8615.
18. Kurhanewicz J, Vigneron DB, Brindle K, et al. Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia. 2011;13:81-97.
19. 13C dehydroascorbate as an endogenous redox sensor for in vivo metabolic imaging. Proc Natl Acad Sci USA. 2011;108:18606-18611.
20. Liang WJ, Johnson D, Jarvis SM. Vitamin C transport systems of mammalian cells. Mol Membr Biol . 2001;18:87-95. (Pubitemid 32521601)
21. Aloj L, Caraco C, Jagoda E, Eckelman WC, Neumann RD. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture. Cancer Res. 1999;59:4709-4714. (Pubitemid 29428980)
22. Medina RA, Owen GI. Glucose transporters: expression, regulation and cancer. Biol Res. 2002;35:9-26. (Pubitemid 34661867)
23. Higashi K, Ueda Y, Sakurai A, et al. Correlation of Glut-1 glucose transporter expression with. Eur J Nucl Med. 2000;27:1778-1785.
24. 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol. 2002;20:379-387.
25. Haber RS, Rathan A, Weiser KR, et al. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer. 1998;83:34-40. (Pubitemid 28299626)
26. 18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review. J Natl Cancer Inst. 2007;99:1753-1767.
27. Reinicke K, Sotomayor P, Cisterna P, Delgado C, Nualart F, Godoy A. Cellular distribution of Glut-1 and Glut-5 in benign and malignant human prostate tissue. J Cell Biochem. 2012;113:553-562.
28. Loening AM, Gambhir SS. AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging. 2003;2:131-137.
29. Rahman I, Kode A, Biswas SK. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat Protoc . 2006;1:3159-3165.
30. Vukovic V, Nicklee T, Hedley DW. Microregional heterogeneity of non-protein thiols in cervical carcinomas assessed by combined use of HPLC and fluorescence image analysis. Clin Cancer Res. 2000;6:1826-1832. (Pubitemid 30305078)
31. Lao K, Xu NL, Sun YA, Livak KJ, Straus NA. Real time PCR profiling of 330 human micro-RNAs. Biotechnol J. 2007;2:33-35. (Pubitemid 46738885)
32. 18F-FDG uptake on PET in pulmonary pleomorphic carcinoma. Lung Cancer. 2011;71:144-150.
33. McBrayer SK, Cheng JC, Singhal S, Krett NL, Rosen ST, Shanmugam M. Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy. Blood. 2012;119:4686-4697.
34. 18F-FDG uptake. J Nucl Med. 2004;45:930-932.
35. 13C compounds. MAGMA . 2009;22:251-256.
36. 13C]-ascorbic and dehydroascorbic acid: vitamin C as a probe for imaging redox status in vivo. J Am Chem Soc. 2011;133:11795-11801.
37. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med. 2001;30:1191-1212. (Pubitemid 32463931)